Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
0.2816 USD -11.22% Intraday chart for GlycoMimetics, Inc. +9.44% -88.07%
06-04 Transcript : GlycoMimetics, Inc. - Special Call
06-04 GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GLYCOMIMETICS, INC. Stock GlycoMimetics, Inc.
 20.45M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.49B -
BIONTECH SE Stock BioNTech SE
 19.4B -
GENMAB A/S Stock Genmab A/S
 16.24B
  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. Charts GlycoMimetics, Inc.
  5. Sector Chart